Klothonova Overview
- Year Founded
-
2025
- Status
-
Private
- Latest Deal Type
-
Joint Venture
- Financing Rounds
-
1
Klothonova General Information
Description
Developer of cell-based therapeutic platforms designed to address age-related diseases through Klotho protein overexpression. The company offers treatment for Alzheimer's disease, heart disease, cancer, kidney disease, other age-related conditions, and longevity promotion.
Contact Information
Corporate Office
- Las Vegas, NV
- United States
Corporate Office
- Las Vegas, NV
- United States
Klothonova Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Klothonova Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Klothonova Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Klothonova FAQs
-
When was Klothonova founded?
Klothonova was founded in 2025.
-
Where is Klothonova headquartered?
Klothonova is headquartered in Las Vegas, NV.
-
What industry is Klothonova in?
Klothonova’s primary industry is Biotechnology.
-
Is Klothonova a private or public company?
Klothonova is a Private company.
-
What is Klothonova’s current revenue?
The current revenue for Klothonova is .
-
Who are Klothonova’s investors?
Austrianova Singapore and Avaí Bio have invested in Klothonova.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
